Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Ekso Bionics Holdings Inc
23E2Current price
1.06 EUR
0 EUR (0.00%)
Last closed
1.22 USD
Company
www.eksobionics.com
ISIN
US2826443010
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
Frankfurt Exchange
Capitalization
26 391 646 USD
Yield for 12 month
+59.60 %
1Y
3Y
5Y
10Y
15Y
23E2
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California. Address: 101 Glacier Point, San Rafael, CA, United States, 94901
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.25 USDP/E ratio
–Dividend Yield
–Current Year
+18 279 000 USD
Last Year
+12 912 000 USD
Current Quarter
+4 950 000 USD
Last Quarter
+3 756 000 USD
Current Year
+9 698 000 USD
Last Year
+6 214 000 USD
Current Quarter
+2 637 000 USD
Last Quarter
+1 951 000 USD
Key Figures 23E2
1 year
3 years
5 years
10 years
EBITDA
-10 312 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.54 %
PEG Ratio
–
Return On Equity TTM
-83.2 %
Wall Street Target Price
6.25 USD
Revenue TTM
18 160 000 USD
Book Value
0.65 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
5.3 %
Dividend Yield
–
Gross Profit TTM
6 749 000 USD
Earnings per share
-0.79 USD
Diluted Eps TTM
-0.79 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-68.41 %
Dividend Analytics 23E2
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 23E2
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
25.03.2020
Dividend Date
25.03.2020
Stock Valuation 23E2
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.4977
Price Sales TTM
1.4533
Enterprise Value EBITDA
0.4628
Price Book MRQ
2.1885
Financials 23E2
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 23E2
For 52 weeks
0.62 USD
3.13 USD
50 Day MA
1.12 USD
Shares Short Prior Month
73 057
200 Day MA
1.47 USD
Short Ratio
2.83
Shares Short
360 882
Short Percent
2.01 %
BeatStart